Verona Pharma

Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD and cystic fibrosis. The Company is listed on the NASDAQ Global Market in the United States under the VRNA ticker and on the London Stock Exchange in the United Kingdom under the VRP.L ticker. Read more here about Verona Pharma's science and innovative theraputics.

Latest press releases

27 June 2017

Verona Pharma Receives Regulatory Approval to Commence Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment in Five Countries across Europe
LONDON, June 27, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces today regulatory approval in five European countries, comprising the United Kingdom, Germany, Romania, Bulgaria, and the Czech Republic, for a Phase 2b dose-ranging trial of RPL554 for maintenance treatment of chronic obstructive pulmonary disease (COPD). The trial is expected to commence in the third quarter of 2017, with top-line data expected in the second ha…

22 June 2017

Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs
LONDON, June 22, 2017 (GLOBE NEWSWIRE) -- Verona Pharma pl…


Jefferies Healthcare Conference

June 8, 2017 from 11:00 AM to 11:55 AM EDT

Current share price


2.00 (1.72%)



0.08 (0.67%)


Contact us

Verona Pharma plc
3 More London Riverside
London SE1 2RE
United Kingdom

T: +44 (0)203 283 4200



Registered address
One Central Square
Cardiff CF10 1FS
United Kingdom

Investor relations contact
ICR, Inc.
T: +1 646-277-1282


Nominated adviser and broker
N+1 Singer
One Bartholemew Lane
London EC2N 2AX

T: +44 (0)203 283 4200


Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us